Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Zai Lab Gross Profit 2016-2019 | ZLAB

Zai Lab gross profit from 2016 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  
Zai Lab Annual Gross Profit
(Millions of US $)
2019 $9
2018 $0
2017 $
2016 $
2015 $
Zai Lab Quarterly Gross Profit
(Millions of US $)
2019-12-31 $5
2019-09-30
2019-06-30
2018-12-31
2017-12-31
2017-06-30
2016-12-31
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.723B $0.013B
Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $141.474B 15.37
Bristol Myers Squibb (BMY) United States $138.771B 10.69
CSL (CSLLY) Australia $91.109B 0.00
Gilead Sciences (GILD) United States $86.313B 12.42
Vertex Pharmaceuticals (VRTX) United States $71.196B 39.73
Regeneron Pharmaceuticals (REGN) United States $68.344B 25.27
Illumina (ILMN) United States $58.702B 67.80
Biogen (BIIB) United States $43.957B 7.52
Seattle Genetics (SGEN) United States $28.153B 0.00
Moderna (MRNA) United States $27.381B 0.00
Genmab (GMAB) Denmark $23.747B 19.54
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $23.603B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.772B 9.49
Genmab (GNMSF) Denmark $22.430B 66.59
BioMarin Pharmaceutical (BMRN) United States $21.698B 157.43
Incyte (INCY) United States $21.268B 0.00
BeiGene (BGNE) Cayman Islands $20.021B 0.00
BioNTech SE (BNTX) Germany $17.440B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.625B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.581B 70.47
Horizon Therapeutics Public (HZNP) Ireland $14.911B 34.89
Exact Sciences (EXAS) United States $13.575B 0.00
Galapagos (GLPG) Belgium $12.242B 36.01
Sarepta Therapeutics (SRPT) United States $12.123B 0.00
ARGENX SE-ADR (ARGX) Netherlands $10.864B 0.00
QIAGEN (QGEN) Netherlands $10.675B 27.09
Bio-Techne Corp (TECH) United States $10.188B 70.52
Immunomedics (IMMU) United States $9.981B 0.00
Novavax (NVAX) United States $9.708B 0.00
Repligen (RGEN) United States $8.121B 128.89
Guardant Health (GH) United States $7.826B 0.00
Ascendis Pharma (ASND) Denmark $7.739B 0.00
Exelixis (EXEL) United States $6.995B 25.63
ACADIA Pharmaceuticals (ACAD) United States $6.800B 0.00
Emergent Biosolutions (EBS) United States $6.719B 26.62
CRISPR Therapeutics AG (CRSP) Switzerland $6.522B 202.04
SWEDISH ORP BIO (BIOVF) Sweden $6.510B 16.19
Vir Biotechnology (VIR) United States $5.914B 0.00
Acceleron Pharma (XLRN) United States $5.730B 0.00
Mirati Therapeutics (MRTX) United States $5.654B 0.00
MyoKardia (MYOK) United States $5.315B 0.00
Adaptive Biotechnologies (ADPT) United States $5.141B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.123B 0.00
Reata Pharmaceuticals (RETA) United States $5.049B 0.00
NeoGenomics (NEO) United States $4.418B 1333.67
MorphoSys AG (MOR) Germany $4.298B 56.33
Bluebird Bio (BLUE) United States $4.228B 0.00
China Biologic Products (CBPO) China $4.204B 23.37
Blueprint Medicines (BPMC) United States $4.125B 0.00
Halozyme Therapeutics (HALO) United States $3.975B 0.00
Amicus Therapeutics (FOLD) United States $3.955B 0.00
Global Blood Therapeutics (GBT) United States $3.930B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.814B 0.00
Arena Pharmaceuticals (ARNA) United States $3.726B 0.00
Denali Therapeutics (DNLI) United States $3.344B 0.00
Sorrento Therapeutics (SRNE) United States $3.294B 0.00
Inovio Pharmaceuticals (INO) United States $3.214B 0.00
Insmed (INSM) United States $2.982B 0.00
Alkermes (ALKS) Ireland $2.965B 62.13
Fate Therapeutics (FATE) United States $2.902B 0.00
Principia Biopharma (PRNB) United States $2.882B 0.00
Amarin (AMRN) Ireland $2.718B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.700B 0.00
Twist Bioscience (TWST) United States $2.692B 0.00
Editas Medicine (EDIT) United States $2.035B 0.00
PHARMA MAR SA (PHMMF) Spain $1.936B 0.00
UniQure (QURE) Netherlands $1.860B 0.00
Ligand Pharmaceuticals (LGND) United States $1.853B 62.74
Mesoblast (MESO) Australia $1.810B 0.00
Viela Bio (VIE) United States $1.788B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.682B 40.04
I-Mab (IMAB) China $1.655B 0.00
Sangamo Therapeutics (SGMO) United States $1.652B 0.00
Eidos Therapeutics (EIDX) United States $1.596B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.554B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.478B 0.00
Zymeworks (ZYME) Canada $1.431B 0.00
Adverum Biotechnologies (ADVM) United States $1.428B 0.00
Zealand Pharma (ZEAL) Denmark $1.373B 0.00
Mersana Therapeutics (MRSN) United States $1.370B 0.00
Intra-Cellular Therapies (ITCI) United States $1.368B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.365B 0.00
Revance Therapeutics (RVNC) United States $1.345B 0.00
Epizyme (EPZM) United States $1.302B 0.00
NGM Biopharmaceuticals (NGM) United States $1.291B 0.00
Cytokineticsorporated (CYTK) United States $1.287B 0.00
REGENXBIO (RGNX) United States $1.277B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
Beam Therapeutics (BEAM) United States $1.262B 0.00
Coherus BioSciences (CHRS) United States $1.235B 7.25
Alector (ALEC) United States $1.198B 0.00
Akcea Therapeutics (AKCA) United States $1.165B 0.00
Arvinas (ARVN) United States $1.160B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.158B 0.00
Alcobra (ARCT) United States $1.156B 0.00
Compugen (CGEN) Israel $1.126B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.049B 0.00
NantKwest (NK) United States $1.035B 0.00
Intellia Therapeutics (NTLA) United States $1.027B 0.00
VBI Vaccines (VBIV) United States $0.973B 0.00
Retrophin (RTRX) United States $0.973B 0.00
Heska (HSKA) United States $0.972B 0.00
Arcus Biosciences (RCUS) United States $0.966B 0.00
Myriad Genetics (MYGN) United States $0.924B 47.65
Athenex (ATNX) United States $0.898B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.856B 0.00
Intrexon (PGEN) United States $0.820B 0.00
Dynavax Technologies (DVAX) United States $0.813B 0.00
Cara Therapeutics (CARA) United States $0.795B 0.00
Codexis (CDXS) United States $0.758B 0.00
Morphic Holding (MORF) United States $0.750B 0.00
Pharming Group (PHGUF) Netherlands $0.745B 17.00
Autolus Therapeutics (AUTL) United Kingdom $0.726B 0.00
Cellectis S.A (CLLS) France $0.718B 0.00
Castle Biosciences (CSTL) United States $0.717B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.686B 0.00
Vericel (VCEL) United States $0.684B 0.00
MiMedx (MDXG) United States $0.662B 0.00
Frequency Therapeutics (FREQ) United States $0.658B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Vanda Pharmaceuticals (VNDA) United States $0.627B 5.50
Kadmon Holdings (KDMN) United States $0.611B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Cue Biopharma (CUE) United States $0.570B 0.00
Agenus (AGEN) United States $0.567B 0.00
Syros Pharmaceuticals (SYRS) United States $0.550B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.541B 0.00
Prothena (PRTA) Ireland $0.515B 0.00
Athersys (ATHX) United States $0.511B 0.00
Kala Pharmaceuticals (KALA) United States $0.500B 0.00
MeiraGTx Holdings (MGTX) United States $0.488B 0.00
AnaptysBio (ANAB) United States $0.485B 0.00
IBio (IBIO) United States $0.481B 0.00
Clovis Oncology (CLVS) United States $0.479B 0.00
Innate Pharma S.A (IPHA) France $0.478B 0.00
Anika Therapeutics (ANIK) United States $0.476B 20.84
UROGEN PHARMA (URGN) United States $0.473B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.470B 0.00
Cel-Sci (CVM) United States $0.460B 0.00
BioDelivery Sciences (BDSI) United States $0.455B 32.21
Protagonist Therapeutics (PTGX) United States $0.451B 0.00
AC Immune SA (ACIU) Switzerland $0.446B 0.00
Avid Bioservices (CDMO) United States $0.433B 0.00
Prometic Life Sciences (LMNL) Canada $0.427B 0.00
Scholar Rock Holding (SRRK) United States $0.411B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.410B 0.00
Puma Biotechnology (PBYI) United States $0.409B 0.00
PDL BioPharma (PDLI) United States $0.399B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.395B 0.00
Kamada (KMDA) Israel $0.387B 16.11
Merus (MRUS) Netherlands $0.387B 0.00
MannKind (MNKD) United States $0.380B 0.00
Albireo Pharma (ALBO) United States $0.372B 0.00
Biofrontera AG (BFRA) Germany $0.370B 0.00
ANI Pharmaceuticals (ANIP) United States $0.364B 8.58
Precision BioSciences (DTIL) United States $0.359B 0.00
CytomX Therapeutics (CTMX) United States $0.347B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.344B 0.00
Seres Therapeutics (MCRB) United States $0.338B 0.00
Geron (GERN) United States $0.338B 0.00
WAVE Life Sciences (WVE) Singapore $0.321B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.308B 0.00
ChromaDex (CDXC) United States $0.302B 0.00
Arbutus Biopharma (ABUS) United States $0.301B 0.00
Starpharma Holdings (SPHRY) Australia $0.293B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.288B 0.00
Affimed (AFMD) Germany $0.288B 0.00
OSMOTICA PHARM (OSMT) United States $0.276B 0.00
Menlo Therapeutics (MNLO) United States $0.267B 0.00
Cellular Biomedicine (CBMG) United States $0.265B 0.00
Celldex Therapeutics (CLDX) United States $0.264B 0.00
NextCure (NXTC) United States $0.264B 0.00
Spero Therapeutics (SPRO) United States $0.261B 0.00
Trevena (TRVN) United States $0.260B 0.00
DBV Technologies S.A (DBVT) France $0.255B 0.00
Pfenex (PFNX) United States $0.254B 0.00
ADMA Biologics Inc (ADMA) United States $0.247B 0.00
Northwest Biotherapeutics (NWBO) United States $0.246B 0.00
Fortress Biotech (FBIO) United States $0.242B 0.00
Verastem (VSTM) United States $0.241B 0.00
Abeona Therapeutics (ABEO) United States $0.239B 0.00
Dyadic (DYAI) United States $0.236B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.236B 0.00
HOOKIPA Pharma (HOOK) United States $0.233B 0.00
Pluristem Therapeutics (PSTI) Israel $0.232B 0.00
Five Prime Therapeutics (FPRX) United States $0.224B 0.00
Selecta Biosciences (SELB) United States $0.220B 0.00
IVERIC Bio (ISEE) United States $0.220B 0.00
Strongbridge Biopharma (SBBP) United States $0.217B 0.00
Aduro Biotech (ADRO) United States $0.205B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.204B 9.50
Exicure (XCUR) United States $0.201B 0.00
Sutro Biopharma (STRO) United States $0.199B 0.00
GENFIT S.A (GNFT) France $0.194B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.193B 0.00
Theratechnologies (THTX) Canada $0.185B 0.00
Aptinyx (APTX) United States $0.182B 0.00
XOMA (XOMA) United States $0.179B 0.00
POXEL SA FRANCE (PXXLF) France $0.177B 0.00
Liquidia Technologies (LQDA) United States $0.173B 0.00
Cerecor (CERC) United States $0.172B 0.00
Aytu Bioscience (AYTU) United States $0.168B 0.00
VTv Therapeutics (VTVT) United States $0.166B 0.00
Bellus Health (BLU) Canada $0.161B 0.00
Kindred Biosciences (KIN) United States $0.157B 0.00
Cidara Therapeutics (CDTX) United States $0.156B 0.00
TELA Bio (TELA) United States $0.151B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.144B 0.00
Eton Pharmaceuticals (ETON) United States $0.142B 0.00
Celyad SA (CYAD) Belgium $0.142B 0.00
Cyclerion Therapeutics (CYCN) United States $0.141B 0.00
Applied Genetic Technologies (AGTC) United States $0.138B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.138B 0.00
Gritstone Oncology (GRTS) United States $0.134B 0.00
VolitionRX (VNRX) United States $0.133B 0.00
Palatin Technologies (PTN) United States $0.131B 3.35
Windtree Therapeutics (WINT) United States $0.122B 0.00
PHASEBIO PHARMA (PHAS) United States $0.122B 0.00
Orgenesis (ORGS) United States $0.120B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
Checkpoint Therapeutics (CKPT) United States $0.118B 0.00
Lumos Pharma (LUMO) United States $0.118B 0.00
Protalix BioTherapeutics (PLX) Israel $0.117B 0.00
Oncobiologics (OTLK) United States $0.117B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
CorMedix Inc (CRMD) United States $0.114B 0.00
Cardiff Oncology (CRDF) United States $0.114B 0.00
SESEN BIO, INC (SESN) United States $0.110B 0.00
Cocrystal Pharma (COCP) United States $0.108B 0.00
Vaccinex (VCNX) United States $0.107B 0.00
Antibe Therapeutics (ATBPF) Canada $0.103B 0.00
AIT Therapeutics (XAIR) United States $0.098B 0.00
AquaBounty Technologies (AQB) United States $0.098B 0.00
Organovo Holdings (ONVO) United States $0.092B 0.00
ARAVIVE, INC (ARAV) United States $0.089B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.084B 0.00
Unum Therapeutics (UMRX) United States $0.082B 0.00
Clearside Biomedical (CLSD) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
DiaMedica Therapeutics (DMAC) United States $0.079B 0.00
Emmaus Life Sciences (EMMA) United States $0.078B 0.00
Proteostasis Therapeutics (PTI) United States $0.078B 0.00
Ecology Coatings (ABVC) United States $0.074B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.073B 0.00
Synlogic (SYBX) United States $0.071B 0.00
Idera Pharmaceuticals (IDRA) United States $0.071B 0.00
Stealth BioTherapeutics (MITO) United States $0.068B 97.50
ANIXA BIOSCIENCES INC (ANIX) United States $0.067B 0.00
Edesa Biotech (EDSA) Canada $0.067B 0.00
Bionano Genomics (BNGO) United States $0.067B 0.00
Soligenix (SNGX) United States $0.065B 0.00
Catalyst Biosciences (CBIO) United States $0.065B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.064B 0.00
Signal Genetics (MGEN) United States $0.062B 0.00
IMMURON (IMRN) Australia $0.062B 0.00
AnPac Bio-Medical Science (ANPC) China $0.061B 0.00
Happiness Biotech Group (HAPP) China $0.060B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.058B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
CollPlant Holdings (CLGN) Israel $0.054B 0.00
Genetic Technologies (GENE) Australia $0.053B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.052B 0.00
Prima BioMed (IMMP) Australia $0.051B 0.00
Curis (CRIS) United States $0.050B 0.00
Apricus Biosciences (SEEL) United States $0.050B 0.00
Spherix (AIKI) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Celsion (CLSN) United States $0.039B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.037B 0.00
Cesca Therapeutics (THMO) United States $0.036B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Prana Biotechnology (ATHE) Australia $0.035B 0.00
OvaScience (MLND) United States $0.035B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.033B 0.00
Chanticleer Holdings (SONN) United States $0.031B 0.00
Novogen (KZIA) Australia $0.031B 0.00
Evogene (EVGN) Israel $0.030B 0.00
Forte Biosciences (FBRX) United States $0.030B 0.00
Cleveland BioLabs (CBLI) United States $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.026B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.023B 0.00
MYOS RENS Technology (MYOS) United States $0.023B 0.00
BioPharmX (TMBR) United States $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
BioCardia (BCDA) United States $0.019B 0.00
Neuralstem (SNCA) United States $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00